Tudor Investment Corp
INBX icon

Tudor Investment Corp’s Inhibrx INBX Stock Holding History

Tudor Investment Corp’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$496K Buy
7,373
+2,731
+59% +$203K ﹤0.01% 2822
2025
Q4 		$367K Buy
+4,642
New +$316K ﹤0.01% 2919

Other funds holding INBX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Tudor Investment Corp's INBX Position: Q1 2026 in Review

Tudor Investment Corp increased its Inhibrx (INBX) stake by 59% in Q1 2026, buying an estimated $203K and bringing the position to 7,373 shares worth $496K. The position accounts for ﹤0.01% of the portfolio, ranked #2822.

Tudor Investment Corp first reported a position in INBX in Q4 2025 and has held it in 2 quarters since. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

  • Tudor Investment Corp held 7,373 shares of Inhibrx worth $496K as of Q1 2026.
  • Tudor Investment Corp bought 2,731 Inhibrx shares in Q1 2026, an estimated $203K.
  • Inhibrx made up ﹤0.01% of Tudor Investment Corp's portfolio in Q1 2026, its #2822 holding.
  • Tudor Investment Corp first reported a position in Inhibrx in Q4 2025 and has held it in 2 quarters since.
  • 135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.